Sign In
Buy SHMN
$0.0012
+0.000055 (+4.80%)
At Close: Jun 03, 2026
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gen
SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
09:30am, Tuesday, 04'th Nov 2025
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gen
SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility
09:30am, Tuesday, 02'nd Sep 2025
CHINO HILLS, CA / ACCESS Newswire / September 2, 2025 / SOHM, Inc. (OTCID:SHMN), a leading pharmaceutical company developing next-generation gene editing solutions, today announced the relocation of i
SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities
09:30am, Tuesday, 26'th Aug 2025
Advanced dCas12a Technology Successfully Modifies Human Cells, Positioning Company for Multi-Target Editing Capabilities CHINO HILLS, CALIFORNIA / ACCESS Newswire / August 26, 2025 / SOHM, Inc. (OTC P
SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement
09:30am, Monday, 21'st Jul 2025
CHINO HILLS, CALIFORNIA / ACCESS Newswire / July 21, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading innovator in pharmaceuticals, nutraceuticals, topicals, and biotechnology, is excited to announce the
SOHM, Inc. Appoints Ravi Kapoor as an Independent Director
09:30am, Monday, 30'th Jun 2025
CHINO HILLS, CA / ACCESS Newswire / June 30, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and well
SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market
09:30am, Tuesday, 24'th Jun 2025
CHINO HILLS, CALIFORNIA / ACCESS Newswire / June 24, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health
SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
09:30am, Wednesday, 11'th Jun 2025
CHINO HILLS, CA / ACCESS Newswire / June 11, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and well
SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development
09:30am, Wednesday, 04'th Jun 2025
CHINO HILLS, CA / ACCESS Newswire / June 4, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and welln
SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
10:15am, Tuesday, 06'th May 2025
CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 / SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development o
CHINO HILLS, CA / ACCESS Newswire / May 2, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces
SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology
09:30am, Thursday, 01'st May 2025
CHINO HILLS, CA / ACCESS Newswire / May 1, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, proudly announces
SOHM, Inc. Announces Patent Allowance/Approval in South Korea
09:30am, Wednesday, 16'th Apr 2025
CHINO HILLS, CA / ACCESS Newswire / April 16, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editi
SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE
09:30am, Thursday, 10'th Apr 2025
CHINO HILLS, CA / ACCESS Newswire / April 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is thrilled to announc
SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations
09:30am, Monday, 07'th Apr 2025
CHINO HILLS, CA / ACCESS Newswire / April 7, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, is proud to announce th
